tirzepatide for menopause symptoms and Hot Flashes: Causes, Management, and When to Seek Help Clinical review: Menopause hormone therapy

FDA's Removal of Tirzepatide from Shortage List Sparks Legal Battle The Food and Drug Administration (FDA) announced the removal of tirzepatide (Zepbound/Mounjaro) from the shortage list in October 2024

The compounded liraglutide products available as part of Ivim Healths Weight Loss Program are not made by Novo Nordisk or any company affiliated with Novo Nordisk

But on the other hand, if the agency sides with the compounders and reverses its decision on tirzepatides shortage status, it risks opening itself up to lawsuits from big pharmaceutical companies like Novo Nordisk and Eli Lilly, companies whose market dominance could be undercut by the production of compounded versions and who made billions of dollars in production investments to keep up with demand

In the future, Retatrutide may be considered for individuals who meet specific health criteria, such as those living with obesity or weight-related conditions, but suitability would depend on personal medical factors

Sperm DNA damage: the possible link between obesity and male infertility, an update of the current literature